A QuESt for speed : rapid qualitative evidence syntheses as a response to the COVID-19 pandemic by Biesty, L. et al.
This is a repository copy of A QuESt for speed : rapid qualitative evidence syntheses as a 
response to the COVID-19 pandemic.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/167969/
Version: Published Version
Article:
Biesty, L., Meskell, P., Glenton, C. et al. (6 more authors) (2020) A QuESt for speed : rapid 
qualitative evidence syntheses as a response to the COVID-19 pandemic. Systematic 
Reviews, 9 (1). 256. 
https://doi.org/10.1186/s13643-020-01512-5
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
METHODOLOGY Open Access
A QuESt for speed: rapid qualitative
evidence syntheses as a response to the
COVID-19 pandemic
Linda Biesty1,2,3* , Pauline Meskell1,2,4,5, Claire Glenton6, Hannah Delaney3,7, Mike Smalle8, Andrew Booth9,
Xin Hui S. Chan10,11, Declan Devane1,3,12,13 and Catherine Houghton1,2,3
Abstract
Background: The COVID-19 pandemic has created a sense of urgency in the research community in their bid to
contribute to the evidence required for healthcare policy decisions. With such urgency, researchers experience
methodological challenges to maintain the rigour and transparency of their work. With this in mind, we offer
reflections on our recent experience of undertaking a rapid Cochrane qualitative evidence synthesis (QES).
Methods: This process paper, using a reflexive approach, describes a rapid QES prepared during, and in response
to, the COVID-19 pandemic.
Findings: This paper reports the methodological decisions we made and the process we undertook. We place our
decisions in the context of guidance offered in relation to rapid reviews and previously conducted QESs. We
highlight some of the challenges we encountered in finding the balance between the time needed for
thoughtfulness and comprehensiveness whilst providing a rapid response to an urgent request for evidence.
Conclusion: The need for more guidance on rapid QES remains, but such guidance needs to be based on actual
worked examples and case studies. This paper and the reflections offered may provide a useful framework for
others to use and further develop.
Keywords: Rapid reviews, Qualitative evidence synthesis, Review methods, Systematic review, COVID-19
Background
This paper describes a rapid review prepared during,
and in response to, the COVID-19 pandemic. The sense
of urgency that this pandemic has created in the re-
search community has been highlighted [1], as re-
searchers are eager to contribute to the evidence base
for clinical and policy decisions. But urgency brings
challenges to conducting research that maintains rigour
and transparency [2]. With this in mind, we offer
reflections on our experience of undertaking a rapid
Cochrane qualitative evidence synthesis (QES)—‘Barriers
and facilitators to healthcare workers’ adherence with in-
fection prevention and control (IPC) guidelines for re-
spiratory infectious diseases: a rapid qualitative evidence
synthesis (QES)’ [3]. Our aim is not to offer predeter-
mined methodological guidance, but to share with the
review community the processes we used and decisions
we made, so as to advance the discourse surrounding
rapid QES.
In March 2020, Cochrane responded to the pandemic
by beginning a process of identifying, refining and priori-
tising research questions to progress as Cochrane rapid
reviews (see https://covidrapidreviews.cochrane.org/
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prioritization). Given the urgent need for evidence to in-
form healthcare practice and policy, Cochrane requested
that COVID-19 related rapid reviews be fast-tracked and
ideally completed within 2 weeks of initiation. Our review
[3], featured amongst the initial suite of Cochrane
COVID-19 rapid reviews, was Cochrane’s first rapid QES.
The contribution rapid reviews can make to strengthen
health policy has been well-documented [4, 5]. Rapid re-
views can potentially support health policy decisions by
providing evidence to inform these decisions [6]. A rapid
synthesis of evidence employs methods, which are ‘acceler-
ated and streamlined’ [7] so that completion is earlier than
with more typical systematic review methods [4]. As needs,
not methods, determine rapid reviews, there can be no con-
sensus on the ideal time to complete. However, from 8
weeks [8] to 12weeks is considered usual [9]. It has been
suggested that rapid models of evidence synthesis are
placed ideally to ensure prompt availability of information
to inform healthcare responses to emergencies [10].
The methodological guidance underpinning rapid re-
views continues to advance but not without challenges
[4, 11, 12]. For rapid reviews of intervention effective-
ness, disagreement centres on which elements should be
prioritised and which should be accelerated [5, 12]. For
review authors undertaking a rapid QES, this may be
even more challenging, we are only aware of one guide
[13]. A scoping review, published in 2019, found an in-
creasing number of published rapid QES (15,—13 pub-
lished reviews and 2 protocols) [2]. However, the
authors of this review called on rapid review authors to
describe their methods explicitly, and the limitations
that time may place on their review [2].
Objectives
The objectives of this paper are (i) to describe decisions
made in the context of a specific review undertaken dur-
ing unprecedented circumstances, and (ii) to contribute
to the discourse surrounding rapid QES.
The team and the work process
From inception to publication, our rapid review took 25
days, with the bulk of the work taking place over 2
weeks. Our published review includes a short reflexive
account offering insight into the professional back-
grounds of the authors and the perspectives we brought
to the review process [3]. For our review, four review au-
thors (the ‘core team’) simultaneously conducted all the
review processes as opposed to a segmented or parallel
approach (i.e. where review authors are allocated differ-
ent stages of the QES). We return to this point about
‘our process’ throughout this paper and propose that the
benefits of this warrant further exploration. Communi-
cation between the core team was constant (frequent
emails, multiple daily videoconference meetings and text
messages). The other members of the team (and the
Cochrane community) answered email queries promptly,
returned feedback within hours, and were on call to con-
sult on methodological or topic-specific questions. This
effort is important to remember but is described rarely
in published reviews, and most rapid reviews offer scant
testimony to the commitment and hours required of
everyone involved.
Methods
Formulating a research question
Our research objective was pre-defined and prioritised
by Cochrane following a request from the World Health
Organisation. This objective encompassed all types of
healthcare workers, IPC guidelines and respiratory infec-
tious diseases [3]. These concepts are broad in their
meaning and added complexity to the search and the re-
view itself. We used the SPICE (Setting, Population,
Phenomenon of Interest, Comparison, Evaluation) [14]
criteria to clarify these concepts. Involving a topic expert
(XHC) on the team was crucial in efficiently defining
our inclusion and exclusion criteria to enable us to con-
duct a review that was responsive to the COVID-19 pan-
demic, yet also relevant to other respiratory infectious
diseases requiring IPC measures.
Search
Interim rapid review guidance from Cochrane recom-
mends that an information specialist should be involved
[15]. In our review, the information specialist was inte-
gral to the team [3], developing a search strategy that
was then peer-reviewed by the team, including our
methodological expert (AB), who drew on his combined
information specialist/systematic review background to
optimise the specificity of the search. It was subse-
quently formally peer-reviewed by a Cochrane informa-
tion specialist.
The aforementioned scoping review [2] reports con-
siderable variation across the number of electronic
databases searched for in rapid QES (ranging from 3
to 7 databases). Due to our restricted timeframe, and
guided by Cochrane’s interim rapid review guidance
[15], we targeted a single MEDLINE database, in-
formed by estimates of high yields of included studies
[16]. We did not include grey literature and record
this as a limitation of our work [3]. Whilst we ac-
knowledge that an exhaustive search may not be ne-
cessary for QES, we undertook an additional scoping
exercise of more than 1500 title and abstracts. We
searched the reference lists of key papers [16, 17].
This supplementary searching was helpful as it
yielded 30 additional studies for screening [3].
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Selection of studies
Cochrane’s interim rapid review guidance suggests a title
and abstract screening approach that involves two
screeners in double independent screening for at least
20% of abstracts with conflict resolution and one screener
thereafter (using a second reviewer to screen all excluded
abstracts to validate the process) [15]. A similar approach
is suggested for full-text screening. Most reviews included
in the scoping review of rapid QES used single reviewer
screening [2]. In our review, the core team double-
screened the title and abstracts independently within
Covidence (Covidence Systematic Review Software. Avail-
able at www.covidence.org). A similar process was applied
to full-text screening. Disagreements were resolved by dis-
cussion or by involving a third reviewer [3].
On reflection, this approach had two specific benefits.
First, constant communication between the core team on
how we understood our eligibility criteria helped us to
minimise bias at the screening stage. Second, the review
authors sensitised themselves to the studies and the data
from the screening stage. Potentially, this early immersion
facilitated our rapid transition across the QES methods of
screening, data extraction and synthesis.
On completion of full-text screening, we identified 36
studies that met our inclusion criteria [3]. Whilst it is
not appropriate to prescribe how many studies should
be included in a QES [17], we were aware that this num-
ber could make it challenging to become sufficiently fa-
miliar with the data [18] and so could impair the quality
of our analysis. We decided to purposively sample 20 of
the studies for inclusion in the synthesis (based on rele-
vance, geographical spread, and depth of insight [19])
[3]. Sampling strategies are increasingly accepted within
QES as they seek variation in concepts rather than an
exhaustive sample [19]. However, sampling strategies
can have important impacts on review findings and
benefit from lengthy consideration. The timeframe we
had to make this decision was, therefore, not ideal. We
have described the sampling strategies we used as a
point of reflection, not as prescriptive guidance.
Data extraction
Cochrane’s interim rapid review guidance recommends
that one reviewer extracts the data using a piloted form
whilst a second reviewer checks the extracted data for
accuracy and completeness [15]. The scoping review of
15 rapid QES noted single reviewer data extraction as
the most commonly reported method [2]. For our re-
view, the core members used a data extraction form
(Google Forms) designed specifically for this synthesis.
The form was piloted on three studies, one reviewer ex-
tracted data, which was reviewed for accuracy and com-
pleteness by a second member of the team [3].
Following minor revisions to the form, each reviewer
extracted data from one study, which was reviewed
resulting in final alterations before full data extraction
from all included studies. Continuous discussion and
moderation across studies were conducted to ensure
consistency.
The data extraction form was developed to support
the “best fit” framework approach [20] used to analyse
and synthesise the evidence (see the ‘Analysis and Syn-
thesis’ section). Categorising the data against a ‘best fit’
framework during the extraction phase, we suggest,
allowed a seamless progression to the ‘best fit’ a priori
framework approach to analyse and synthesise findings.
Assessment of methodological limitations
Cochrane’s interim rapid review guidance suggests
that quality assessment of included studies is con-
ducted by a single reviewer, with verification of all
judgements by a second reviewer [15]. Most of the
rapid QES reported in the scoping review [2] con-
ducted a quality assessment (mainly using the Critical
Appraisal Skills Programme Qualitative Checklist Tool
(CASP) [21]). We, similarly, used an adaptation of the
CASP tool (the adapted tool is documented in the
published rapid QES). Each included study was ap-
praised independently by two core team members
with disagreements resolved through discussion [3].
On reflection, we could have considered a single re-
viewer assessment with a process of verification.
However, we persisted with double, independent as-
sessments in seeking to balance speed with rigour.
Analysis and synthesis
Cochrane’s interim rapid review guidance on analysis
was not considered relevant to our review, given its
focus on effectiveness reviews [15]. The scoping review
of rapid QES reports use of the same approaches used
by regular QES [2]. We used a ‘best fit’ framework ap-
proach [20, 22]. This deductive approach is considered
by its creators, and others [23], as particularly suitable
for rapid synthesis [22], and this guided our decision.
This pragmatic method builds on an a priori framework,
enriching existing theory, rather than employing a
grounded or inductive form of synthesis [24, 25]. We
identified a pre-existing framework [26] that we used to
analyse the studies under the domains of organisational,
environmental and individual factors that can impact
IPC guideline adherence.
In keeping with ‘our process’, the core team conducted
analysis and synthesis simultaneously. Using the ‘best fit’
framework approach to inform data extraction meant
that individual reviewers could analyse the data to popu-
late different domains of the framework. We engaged in
several online discussions to ensure consistency across
analysis and synthesis, reduce overlap in the findings by
Biesty et al. Systematic Reviews           (2020) 9:256 Page 3 of 6
mapping the range and nature of reviewed concepts and
identify how the themes addressed the review question
and review aim [3]. We believe that this contemporan-
eous critical peer review of synthesised findings made
our process more trustworthy, contributing to the coher-
ence and relevance of the findings.
Engaging in all stages of the QES, from screening to
synthesis, helped the review authors move between the
data and the developing themes more effectively. In our
experience, this intense part of the review, given the
immersion needed during analysis, requires uninter-
rupted focus facilitated by conversations conducted in
real-time.
Assessing the confidence in the findings
Cochrane’s interim guidance about assessing the cer-
tainty of evidence in rapid reviews suggests a single re-
viewer approach, with verification from a second
reviewer [15]. This topic is not documented in the scop-
ing review of rapid QES [2]. For our review, the core
team independently used the Confidence in the Evidence
from Reviews of Qualitative Research (GRADE-CERQ-
ual) approach to assess confidence in the findings [27].
The review authors initially applied GRADE-CERQual to
those findings that were within the same domains they
had explored previously in-depth during the synthesis
stage. The final assessment was based on a consensus
across the core team [3]. Whilst our assessment was
rigorous, we did not have time to edit and include full
evidence profiles in the published review (the evidence
profiles are now complete and are documented in Ap-
pendix 2 of the published rapid QES).
Having team members who were familiar with
GRADE-CERQual was important for expediting this
stage. We were able to refine our approach in line with
previous experiences and used a piloting process where
each of the core team performed the assessment on
three key findings and presented back to the others pro-
viding the rationale for the level of confidence we
awarded. This pilot exercise was valuable in identifying
any ambiguity in our GRADE-CERQual judgements
early in the process. The review authors undertaking the
GRADE-CERQual assessment had conducted the data
extraction and the assessment of methodological limita-
tions in relation to these studies informing the findings.
Again, this knowledge and familiarity helped to expedite
the process.
Developing implications for practice
Developing implications for practice was not a specific
requirement in the Cochrane interim rapid review guid-
ance. However, we felt that to support decision-makers,
this section was critical. Our review team included an
editor from the Cochrane Effective Practice and
Organisation of Care Group (EPOC) with experience of
communicating findings in this way [28], who could pre-
pare this section quickly. This work involved mapping
individual review findings into questions for consider-
ation by decision-makers. We also included these ques-
tions in an evidence summary for end users [29].
To ensure that this summary was accessible and relat-
able to end users, we invited 18 nurses, doctors and care
home staff from different continents and areas of health-
care to review the summary. Fifteen volunteers
responded within 24 h, and minor edits were made ac-
cordingly. We sourced volunteers to translate the sum-
mary into Spanish, Portuguese, French and Norwegian.
Volunteers also translated the plain language summary
of the review into five languages. In addition, we re-
corded a podcast, since translated into multiple lan-
guages, developed an infographic and featured in
Evidence Aid [30].
These efforts and generosity from others increased the
accessibility and usefulness of the rapid QES findings.
Future rapid review guidance needs to consider know-
ledge translation as a key element.
Discussion
Our first objective in this paper was to describe how we
undertook a rapid QES at a unique moment in time. We
describe how the process enabled us to meet the remit
and timeline of Cochrane’s COVID-19 rapid reviews.
Our second objective was to contribute to the discourse
surrounding rapid QES. The need for more guidance on
rapid QES remains, but such guidance needs to be based
on worked examples. This paper may provide a useful
framework for others to use and further develop.
We are mindful of the potential criticism that rapid re-
viewers may privilege processes that are generic across
all review types, rather than preserve the philosophical
underpinnings of qualitative research [2]. Concerns
about superficial QES approaches already exist [31], and
this critique must inform the decisions and claims that
reviewers make about their outputs. Campbell et al. sug-
gest that concerns about potential limitations must be
weighed against the argument that, during periods of
limited resources and time, ‘something is better than
nothing’ [2]. The limitations of our work are docu-
mented here and within the published review [3]. Produ-
cing a timely review for the research and healthcare
community required some decisions to compromise. We
do not suggest that these decisions are easy to make; our
team would have enjoyed making methodological deci-
sions under less pressured conditions. However, the lim-
ited available time certainly did not restrict the depth of
our engagement and discussion. Responding effectively
to a question about COVID-19 during a global pan-
demic necessitates, or at least permits dynamic,
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pragmatic, and responsive attitudes to guide decision-
making. The challenge lies in finding the balance be-
tween the time needed for thoughtfulness and the need
to respond rapidly.
Our final points remain as reflexive thoughts as we
highlight the factors that enabled the completion of our
rapid review. The entire process, from initiation to pub-
lication took 25 days. Several factors influenced our abil-
ity to complete the review within this timeframe. We
highlight the broader team of supporters, including the
editors, peer reviewers, translators, healthcare workers,
end-user stakeholders, and the broader Cochrane com-
munity. The membership of our immediate team and
the support we received from the wider community was
critical in completing and publishing our review within
this timeframe. The core team had worked together pre-
viously and this also enhanced our completion trajec-
tory. The merits of conducting rapid research with
people who recognise each other’s work ethic, skill sets
and personalities receive almost no attention in the lit-
erature. This should be explored in further methodo-
logical discussions. The process we employed relied on
the core team moving together through the methods of
this QES. We believe this approach called for a frequent
and in-depth discussion in real-time. This constant com-
munication (and follow-up consultations with the wider
team) also supported the reflexivity required to balance
speed with rigour.
International experts in methodology and topic areas
joined this team at a time when they were already inun-
dated with commitments to the COVID-19 response.
The generosity of everyone to answer this question
played a role that cannot be underestimated. In addition,
through the Cochrane structure, the team had access to
an international network offering specialised methodo-
logical and practical support. Cochrane EPOC’s editorial
team maintains high levels of QES expertise providing
essential guidance for sections of the review, as well as
experience in dissemination and end-user input. The
Cochrane community was quickly able to identify peer
reviewers and copy editors, who contributed within the
timeline. We cannot speculate whether such commit-
ment would have been possible at another time, nor the
extent to which we could have harnessed these energies
outside the exceptional circumstances and urgency of
this review question. We are confident that there are les-
sons here for the future of how evidence syntheses are
conducted.
Conclusion
This paper offers insights into conducting a rapid QES
during the COVID-19 pandemic. We have highlighted
our decisions, the process we undertook and areas for
consideration by the review community. Members of the
Oxford Centre for Evidence-Based Medicine have sug-
gested previously that rapid reviews would be more ap-
propriately rebranded as ‘restricted systematic reviews’
[32]. Regardless of the label, we return to an earlier re-
flection that calendar dates may denote rapid comple-
tion, but they do not attest to the extensive hours and
intensive effort required; a point of which those who
agree to take on such endeavours must be aware!
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